Novanta (NASDAQ: NOVT) director reports 748-share sale under 10b5-1 plan

Rhea-AI Filing Summary

Novanta Inc. director reported a small stock sale under a pre-arranged trading plan. On 12/15/2025, the reporting person sold 748 shares of Novanta common stock at a price of $119.67 per share. After this transaction, the director directly beneficially owns 747 shares of Novanta common stock. The filing notes that the sale was carried out under a pre-established Rule 10b5-1 trading plan adopted on September 10, 2025, which is designed to allow insiders to sell shares according to a preset schedule.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Secor Thomas N

(Last) (First) (Middle)

C/O NOVANTA INC.

125 MIDDLESEX TURNPIKE

(Street)

BEDFORD MA 01730

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NOVANTA INC [ NOVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		S(1)		748	D	$119.67	747	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2025.

Remarks:

Power of Attorney on file

	/s/ John Burke, Attorney-in-Fact	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Novanta Inc (NOVT) report in this Form 4?

The filing reports that a director of Novanta Inc. sold 748 shares of Novanta common stock on 12/15/2025 at a price of $119.67 per share.

How many Novanta (NOVT) shares does the director own after this transaction?

Following the reported sale, the director beneficially owns 747 shares of Novanta Inc. common stock in direct ownership.

Was the Novanta (NOVT) insider sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the sales "were effected pursuant to a pre-established Rule 10b5-1 trading plan" that was adopted on September 10, 2025 by the reporting person.

What is the relationship of the reporting person to Novanta Inc (NOVT)?

The reporting person is identified as a Director of Novanta Inc., as indicated in the relationship section of the filing.

Is this Novanta (NOVT) Form 4 filed by one reporting person or a group?

The document indicates that the Form 4 is filed by one reporting person, not by more than one reporting person.

What address is listed for the reporting person in the Novanta (NOVT) Form 4?

The address listed is C/O Novanta Inc., 125 Middlesex Turnpike, which is provided as the street address for the reporting person.